1,700,000 SHARES MIDDLESEX WATER COMPANY COMMON STOCK UNDERWRITING AGREEMENT
1,700,000
SHARES
MIDDLESEX
WATER COMPANY
COMMON
STOCK
-------------------
-------------------
Philadelphia,
Pennsylvania
June 8,
0000
XXXXXX
XXXXXXXXXX XXXXX LLC
XXXXXX X.
XXXXX & CO., LP
As
Representatives of the Several Underwriters Named in Schedule I
hereto
c/o
Janney Xxxxxxxxxx Xxxxx LLC
0000
Xxxxxx Xxxxxx
Xxxxxxxxxxxx,
XX 00000
Ladies
and Gentlemen:
Middlesex
Water Company, a New Jersey corporation (the “Company”), proposes, subject to
the terms and conditions stated herein, to sell to the several Underwriters
named in Schedule
I hereto (the “Underwriters”), for whom Xxxxxx Xxxxxxxxxx Xxxxx LLC and
Xxxxxx X. Xxxxx & Co., LP are serving as Representatives (the
“Representatives”), an aggregate of 1,700,000 shares of the Company’s Common
Stock, no par value (the “Common Shares”). The 1,700,000 Common
Shares to be sold to the Underwriters by the Company are referred to herein as
the “Firm Shares.” The respective amounts of the Firm Shares to be
purchased by the several Underwriters are set forth opposite their names in
Schedule I
hereto. The Firm Shares shall be offered to the public at a public
offering price of $15.21 per Firm Share (the “Offering Price”).
In order
to cover over-allotments in the sale of the Firm Shares, the Underwriters may,
at the Underwriters’ election and subject to the terms and conditions stated
herein, purchase ratably in proportion to the amounts set forth opposite their
respective names in Schedule I hereto,
for the Underwriters’ own accounts up to 255,000 additional Common Shares from
the Company. Such 255,000 additional Common Shares are referred to
herein as the “Optional Shares.” If any Optional Shares are
purchased, the Optional Shares shall be purchased for offering to the public at
the Offering Price and in accordance with the terms and conditions set forth
herein. The Firm Shares and the Optional Shares are referred to
collectively herein as the “Shares.”
1
In
consideration of the mutual agreements contained herein, the Company and the
Underwriters, intending to be legally bound, confirm their agreement as
follows:
1. Representations and
Warranties of the Company. The Company
represents and warrants to, and agrees with, the several Underwriters
that:
(a) The
Company has prepared and filed with the Securities and Exchange Commission (the
“SEC”), in accordance with the provisions of the Securities Act of 1933, as
amended (the “Act”), and the rules and regulations thereunder (the
“Regulations”), a registration statement on Form S-3 (File No. 166425),
including a prospectus, relating to the Shares, which was declared effective by
the SEC as of 5:00 p.m. on May 19, 2010 (the “Effective Time”). The
term “Registration Statement” as used herein means such registration statement
(including all exhibits and information incorporated by reference therein) as
amended to the date of this Agreement, and includes information (if any)
contained in a form of prospectus or prospectus supplement that is deemed
retroactively to be part of the Registration Statement pursuant to Rule 430B
under the Act, to be part of the registration statement as of the time specified
in Rule 430B. If it is contemplated, at the time this Agreement
is executed, that a post-effective amendment to the Registration Statement will
be filed and must be declared effective before the offering of the Shares may
commence, the term “Registration Statement” as used herein shall mean the
Registration Statement as amended by such post-effective
amendment. If the Company has filed or files on or after the date of
this Agreement a registration statement to register additional Common Shares
pursuant to Rule 462(b) under the Act (the “Rule 462(b) Registration
Statement”), then any reference herein to the term “Registration Statement”
shall be deemed to include such Rule 462(b) Registration
Statement. The term “Base Prospectus” shall mean the base prospectus
filed as part of the Registration Statement in the form in which it has most
recently been filed with the SEC on or prior to the date of this Agreement, and
not including any prospectus supplement filed relating to the offering of the
Shares. The term “Preliminary Prospectus” shall mean any preliminary
prospectus supplement relating to the Shares, together with the Base Prospectus,
and filed with the SEC pursuant to Rule 424(a) of the
Regulations. The term “Statutory Prospectus” shall mean the
Preliminary Prospectus, as amended or supplemented, immediately prior to the
Initial Sale Time (as defined below), including any document incorporated by
reference therein. The term “Prospectus” shall mean the final
prospectus supplement relating to the Shares, together with the Base Prospectus,
that is first filed pursuant to Rule 424(b) after the Effective
Time. The term “Issuer Free Writing Prospectus” shall have the
meaning ascribed to it in Rule 433 of the Regulations relating to the Shares, in
the form filed or required to be filed with the SEC or, if not required to be
filed, in the form retained in the Company’s records pursuant to Rule 433(g) of
the Regulations. The term “Disclosure Package” shall mean (i) the
Statutory Prospectus, (ii) the Issuer Free Writing Prospectus, if any,
identified in Schedule II
hereto, and (iii) any other free writing prospectus defined in Rule 405 of the
Regulations that is required to be filed by the Company with the SEC or retained
by the Company under Rule 433 of the Regulations and that all parties hereto
expressly agree to treat as part of the Disclosure Package (the “Other Free
Writing Prospectus”). For purposes of this Agreement, the “Initial
Sale Time” shall mean 5:00 p.m. (Eastern Time) on the date of this
Agreement. All references in this Agreement to the Registration
Statement, the Rule 462(b) Registration Statement, the Base Prospectus, a
Preliminary Prospectus, the Statutory Prospectus, the Prospectus, the Issuer
Free Writing Prospectus, the Other Free Writing Prospectus or any amendments or
supplements to any of the foregoing, shall include any copy thereof filed with
the SEC pursuant to its Electronic Data Gathering, Analysis and Retrieval System
(“XXXXX”).
2
(b) The
Registration Statement has become effective under the Act, and the SEC has not
issued any stop order suspending the effectiveness of the Registration Statement
or preventing or suspending the use of the Statutory Prospectus or the
Prospectus, nor has the SEC instituted or threatened to institute proceedings
with respect to such an order. No stop order suspending the sale of
the Shares in any jurisdiction designated by the Representatives as provided for
in Section 5(f) of this Agreement has been issued, and no proceedings for that
purpose have been instituted or threatened. The Company has complied
in all material respects with all requests of the SEC, or requests of which the
Company has been advised of any state or foreign securities commission in a
state or foreign jurisdiction designated by the Representatives as provided for
in Section 5(f) of this Agreement, for additional information to be included in
the Registration Statement, the Disclosure Package or the
Prospectus.
(c) (i) The
Registration Statement complied at the Effective Time and, as amended or
supplemented, complies on the date hereof and will comply on the Closing Date
(as defined below) and any Option Closing Date (as defined below), in all
material respects, with the requirements of the Act and the Regulations,
(ii) the Registration Statement, at the Effective Time, did not contain any
untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading,
(iii) the Disclosure Package, at the time it was filed and as of the
Initial Sale Time, complied in all material respects with the requirements of
the Act and the Regulations, (iv) the Disclosure Package at the time it was
filed and as of the Initial Sale Time, did not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not
misleading, (v) the Prospectus complied at the time it is filed and, as amended
or supplemented, will comply as of the Closing Date and any Option Closing Date,
in all material respects with the requirements of the Act and the Regulations,
and the Prospectus, as so amended or supplemented, will not contain
any untrue statement of a material fact or omit to state a material fact
necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however that the
representations and warranties set forth in this paragraph do not apply to
omissions from or statements in the Registration Statement, the Disclosure
Package or the Prospectus based upon and in conformity with written information
furnished to the Company by any Underwriter through the Representatives
specifically for use therein, it being understood and agreed that the only
information furnished in writing by any Underwriter for use in the Registration
Statement, the Disclosure Package and the Prospectus is the information as set
forth in Section 13 of this Agreement, and (vi) the statistical and
market-related data included or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus are based on or derived
from sources that the Company believes to be reliable and accurate.
(d) As of the
Initial Sale Time, the Disclosure Package complied in all material respects with
the Act and the Regulations and, if filed by electronic transmission pursuant to
XXXXX (except as may be permitted by Regulation S-T under the Act), was
identical to the copy thereof delivered to the Underwriters for use in
connection with the offer and sale of the Shares. The Disclosure
Package, at the Initial Sale Time, did not, and at the Closing Date will not,
contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not
misleading. The preceding sentence does not apply to omissions from
or statements in the Disclosure Package based upon and in conformity with
written information furnished to the Company by any Underwriter through the
Representatives specifically for use therein, it being understood and agreed
that the only such information furnished by any Underwriter for use in the
Disclosure Package is the information as set forth in Section 13 of this
Agreement.
3
(e) The
Company (including its agents and representatives, other than the Underwriters
in their capacity as such) has not used, authorized, approved or referred to and
will not use, authorize, approve or refer to any Issuer Free Writing Prospectus,
other than the documents listed on Schedule II
hereto. Each such Issuer Free Writing Prospectus complied in all
material respects with the Act and the Regulations and has been filed in
accordance with the Act and the Regulations (to the extent required
thereby). Each Issuer Free Writing Prospectus, as of its issue date
and at all subsequent times through the completion of the public offer and sale
of the Shares or until any earlier date of which the Company notified or
notifies the Representatives as described in the next sentence, did not, does
not and will not include any information that conflicted, conflicts or will
conflict with the information contained in the Registration
Statement. If at any time following issuance of an Issuer Free
Writing Prospectus, there occurred or occurs an event or development as a result
of which such Issuer Free Writing Prospectus conflicted or would conflict with
the information then contained in the Registration Statement or included or
would include an untrue statement of a material fact or omitted or would omit to
state a material fact necessary in order to make the statements therein, in the
light of the circumstances prevailing at that subsequent time, not misleading,
(i) the Company has promptly notified or will promptly notify the
Representatives and (ii) the Company has promptly amended or will promptly amend
or supplement such Issuer Free Writing Prospectus to eliminate or correct such
conflict, untrue statement or omission. The foregoing sentences do
not apply to omissions from or statements in any Issuer Free Writing Prospectus
based upon and in conformity with written information furnished to the Company
by any Underwriter through the Representatives specifically for use therein, it
being understood and agreed that the only such information furnished by any
Underwriter for use in any Issuer Free Writing Prospectus is the information as
set forth in Section 13 of this Agreement.
(f) The
Company has not distributed and will not distribute, prior to the later of the
last Option Closing Date (as defined below) and the completion of the
Underwriters’ distribution of the Shares, any offering material in connection
with the offering and sale of the Shares other than the Registration Statement,
the Disclosure Package or the Prospectus.
(g) The
documents incorporated by reference into the Prospectus pursuant to Item 12 of
Form S-3 under the Act, at the time they were filed with the SEC, complied in
all material respects with the requirements of the Securities Exchange Act of
1934, as amended (the “Exchange Act”) and with the rules and regulations
promulgated under or pursuant to the Exchange Act, and did not contain any
untrue statement of material fact or omit to state a material fact required to
be stated therein, or necessary to make the statements therein not
misleading.
4
(h) There are
no legal or governmental proceedings pending or, to the knowledge of the
Company, threatened to which the Company or any of its Subsidiaries is a party
or to which any of the properties of the Company or any Subsidiary are subject
that are required to be described in the Registration Statement, the Disclosure
Package or the Prospectus and are not so described or any statutes, regulations,
contracts or other documents that are required to be described in the
Registration Statement, the Disclosure Package or the Prospectus or to be filed
as exhibits to the Registration Statement that are not described or filed as
required.
(i) The
Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of New Jersey, with all necessary power and
authority, corporate or otherwise, and all required licenses, permits,
certifications, registrations, approvals, consents and franchises to own or
lease and operate its properties and to conduct its current business as
described in the Registration Statement, the Disclosure Package and the
Prospectus, and to execute, deliver and perform this Agreement. Each
of Tidewater Utilities, Inc., a Delaware corporation (“Tidewater”), Tidewater
Environmental Services, Inc., a Delaware corporation, Pinelands Water Company, a
New Jersey corporation, Pinelands Wastewater Company, a New Jersey corporation,
Utility Services Affiliates, Inc., a New Jersey corporation, Utility Services
Affiliates (Perth Amboy), Inc., a New Jersey corporation, and Twin Lakes
Utilities, Inc., a Pennsylvania corporation, is a wholly owned subsidiary of the
Company and together with each of Southern Shores Water Company, LLC (“Southern
Shores”), a Maryland limited liability company and wholly owned subsidiary of
Tidewater, and White Xxxxx Environmental Systems, Inc. (“White Xxxxx”), a
Delaware corporation and wholly owned subsidiary of Tidewater, collectively,
shall herein be referred to individually as a “Subsidiary” and collectively as
the “Subsidiaries.” Each Subsidiary of the Company has been duly
incorporated or formed and is a validly existing corporation or limited
liability company, as the case may be, in good standing under the laws of the
jurisdiction of its incorporation or formation, and has the power and authority,
corporate or otherwise, and all required licenses, permits, certifications,
registrations, approvals, consents and franchises to own or lease and operate
its properties and to conduct its current business. The Company and
the Subsidiaries are duly qualified to do business as foreign entities, and are
in good standing, in all jurisdictions in which such qualification is required,
except where the failure to so qualify would not have a material adverse effect
on the general affairs, properties, assets, operations, condition (financial or
otherwise), results of operations, stockholders’ equity, business or prospects
(collectively, the “Business Conditions”) of the Company and the Subsidiaries
taken as a whole. References in this Agreement to materiality as
applicable to the Subsidiaries shall mean material to the Business Conditions of
the Company and the Subsidiaries taken as a whole.
(j) All of
the outstanding shares of capital stock of each of the Subsidiaries have been
duly authorized and validly issued, are fully paid and non-assessable and are
owned by the Company or Tidewater, as the case may be, free and clear of all
liens, encumbrances and security interests; and no options, warrants or other
rights to purchase, agreements or other obligations to issue, or other rights to
convert any obligations into shares of capital stock or ownership interests in
each of the Subsidiaries or securities convertible into or exchangeable for
capital stock of, or other ownership interests in any of the Subsidiaries are
outstanding, except as disclosed in the Registration Statement, the Disclosure
Package and the Prospectus. Neither the Company nor the Subsidiaries
owns any stock or other interest whatsoever, whether equity or debt, in any
corporation, partnership or other entity other than the Company’s and
Tidewater’s ownership of the Subsidiaries.
5
(k) This
Agreement has been duly authorized, executed and delivered by the Company and
constitutes its legal, valid and binding obligation, enforceable against the
Company in accordance with its terms, except as enforcement may be limited by
bankruptcy, insolvency or other similar laws affecting the enforcement of
creditors’ rights generally and subject to applicability of general principles
of equity and except, as to this Agreement, as rights to indemnity and
contribution may be limited by federal and state securities laws or principles
of public policy.
(l) The
execution, delivery and performance of this Agreement and the transactions
contemplated herein, do not and will not, with or without the giving of notice
or the lapse of time, or both, (i) conflict with any term or provision of the
Company’s or any Subsidiary’s respective charter documents or Bylaws; (ii)
result in a breach of, constitute a default under, result in the termination or
modification of, result in the creation or imposition of any lien, security
interest, charge or encumbrance upon any of the properties of the Company or the
Subsidiaries or require any payment by the Company or any of the Subsidiaries or
impose any liability on the Company or any of the Subsidiaries pursuant to, any
contract, indenture, mortgage, deed of trust, commitment or other agreement or
instrument to which the Company or any of the Subsidiaries is a party or by
which any of their respective properties are bound or affected other than this
Agreement; (iii) assuming compliance with Blue Sky laws and the rules of
the Financial Industry Regulatory Authority, Inc. (“FINRA”) applicable to
the offer and sale of the Shares, violate any law, rule, regulation, judgment,
order or decree of any government or governmental agency, instrumentality or
court, domestic or foreign, having jurisdiction over the Company or the
Subsidiaries or any of their respective properties or businesses; or
(iv) result in a breach, termination or lapse of the Company’s or the
Subsidiaries’ corporate power and authority to own or lease and operate their
respective properties and conduct their respective businesses.
(m) At the
date or dates indicated in the Registration Statement, the Disclosure Package or
the Prospectus, the Company had or will have the capitalization set forth in the
Registration Statement, the Disclosure Package and the Prospectus under the
caption “Capitalization” and will have, as of the issuance of the Firm Shares on
the Closing Date, the as-adjusted capitalization set forth in the Prospectus as
of the date indicated therein under the caption “Capitalization.” At
the Effective Time and on the Closing Date and any Option Closing Date, there
were no and will be no options or warrants or other outstanding rights to
purchase, agreements or obligations to issue or agreements or other rights to
convert or exchange any obligation or security into, capital stock of the
Company or securities convertible into or exchangeable for capital stock of the
Company, except as described in the Registration Statement, the Disclosure
Package or the Prospectus or the grant of options after the date of the
Registration Statement, the Disclosure Package or the Prospectus under option
plans of the Company. The information in the Registration Statement,
the Disclosure Package and the Prospectus, insofar as it relates to all
outstanding options and other rights to acquire securities of the Company as of
the dates referred to in the Registration Statement, the Disclosure Package and
the Prospectus, is true and correct in all material respects.
6
(n) The
currently outstanding shares of the Company’s capital stock have been duly
authorized and are validly issued, fully paid and non-assessable, and none of
such outstanding shares of the Company’s capital stock has been issued in
violation of any preemptive rights or similar rights of any security holder of
the Company. The holders of the outstanding shares of the Company’s
capital stock are not subject to personal liability solely by reason of being
such holders. All previous offers and sales of the outstanding shares
of the Company’s capital stock, whether described in the Registration Statement,
the Disclosure Package or the Prospectus were made in compliance with applicable
federal, state and foreign securities laws. The authorized capital
stock of the Company, including, without limitation, the outstanding Common
Shares and the Shares being issued, conform in all material respects with the
descriptions thereof in the Registration Statement, the Disclosure Package and
the Prospectus, and such descriptions conform in all material respects with the
instruments defining the same. The description of the Company’s stock
plans, equity compensation plans and other equity arrangements, and the rights
granted thereunder, set forth in the Registration Statement, the Disclosure
Package and the Prospectus accurately and fairly presents, in all material
respects, the information required to be shown with respect to such plans,
arrangements and rights.
(o) There are
no contracts, agreements or understandings between the Company or any of its
Subsidiaries and any person granting such person the right to require the
Company to file a registration statement under the Act with respect to any
securities of the Company owned or to be owned by such person or to require the
Company to include such securities in the securities registered pursuant to the
Registration Statement or in any securities being registered pursuant to any
other registration statement filed by the Company under the Act.
(p) The
Shares have been duly and validly authorized, and, when issued and delivered
against payment therefor as contemplated by this Agreement, the Shares will be
validly issued, fully paid and non-assessable, and the holders thereof will not
be subject to personal liability solely by reason of being such
holders. The certificates, if any, representing the Shares are in
proper legal form under, and conform in all respects to the requirements of, the
New Jersey Business Corporation Act, as amended. Neither the filing
of the Registration Statement or the Prospectus nor the offering or sale of
Shares as contemplated by this Agreement gives any security holder of the
Company any rights for or relating to the registration of any Common Shares or
any other capital stock of the Company or any rights to convert or have redeemed
or otherwise receive anything of value with respect to any other security of the
Company.
(q) No
consent, approval, authorization, order, registration, license or permit of, or
filing or registration with, any court, government, governmental agency,
instrumentality or other regulatory body or official is required for the valid
and legal execution, delivery and performance by the Company of this Agreement
and the consummation of the transactions contemplated hereby or described in the
Registration Statement, the Disclosure Package or the Prospectus, except
(i) approval by the New Jersey Board of Public Utilities, which has been
obtained, and (ii) such as may be required for the registration of the Shares
under the Act, the Exchange Act, and for compliance with the applicable state
securities or Blue Sky laws or the Bylaws, rules and other pronouncements of
FINRA.
7
(r) The
Common Shares (including the Shares) are registered pursuant to Section 12(b) of
the Exchange Act. The issued and outstanding Common Shares are listed
on the Nasdaq Global Select Market (“Nasdaq”). Neither the Company
nor, to the Company’s knowledge, any other person has taken any action designed
to cause, or likely to result in, the termination of the registration of the
Common Shares under the Exchange Act. The Company has not received
any notification that the SEC, Nasdaq or FINRA is contemplating terminating such
registration or inclusion.
(s) The
statements in the Registration Statement, the Disclosure Package and the
Prospectus, insofar as they are descriptions of or references to contracts,
agreements or other documents, are accurate in all material respects and present
or summarize fairly, in all material respects, the information required to be
disclosed under the Act or the Regulations, and there are no contracts,
agreements or other documents, instruments or transactions of any character
required to be described or referred to in the Registration Statement, the
Disclosure Package or the Prospectus or to be filed as exhibits to the
Registration Statement that have not been so described, referred to or filed, as
required.
(t) Each
contract or other instrument (however characterized or described) to which the
Company or any of the Subsidiaries is a party or by which any of their
respective properties or businesses is bound or affected and which is material
to the conduct of the Company’s, or the Subsidiaries’ business has been duly and
validly executed by the Company or the Subsidiaries, as applicable, and, to the
knowledge of the Company, has been duly and validly executed by the other
parties thereto. Each such contract or other instrument is in full
force and effect and, to the Company’s knowledge, is enforceable against the
parties thereto in accordance with its terms, except as enforcement may be
limited by bankruptcy, insolvency or other similar laws affecting the
enforcement of creditors’ rights generally and subject to applicability of
general principles of equity, and neither the Company nor any of the
Subsidiaries is, and to the Company’s knowledge no other party thereto is, in
default thereunder, and no event has occurred that, with the lapse of time or
the giving of notice, or both, would constitute a default under any such
contract or other instrument. All necessary consents under such
contracts or other instruments to the disclosure in the Registration Statement,
the Disclosure Package or the Prospectus with respect thereto have been
obtained.
(u) The
consolidated financial statements of the Company (including the notes thereto)
filed as part of, or incorporated by reference in, the Registration Statement,
the Disclosure Package and the Prospectus present fairly, in all material
respects, the financial position of the Company as of the respective dates
thereof, and the results of operations and cash flows of the Company for the
periods indicated therein, and have been prepared in conformity with generally
accepted accounting principles. The financial information included in
the Registration Statement, the Disclosure Package and the Prospectus fairly
state in all material respects the information required to be stated therein in
relation to the financial statements taken as a whole. The financial
information included in the Registration Statement, the Disclosure Package or
Prospectus under the captions “Prospectus Summary - Summary Consolidated
Financial Data,” “Use of Proceeds” and “Capitalization” presents fairly the
information shown therein and has been compiled on a basis consistent with that
of the financial statements included or incorporated by reference in the
Registration Statement, the Disclosure Package and the
Prospectus. The unaudited pro forma adjustments to financial
information in the Registration Statement, the Disclosure Package and the
Prospectus have been properly applied to the historical amounts in the
compilation of that information to reflect the sale by the Company of the Shares
offered thereby at an assumed offering or actual price set forth in the
Registration Statement, the Disclosure Package or the Prospectus, as the case
may be, and the application of the estimated net proceeds
therefrom.
8
(v) Since the
respective dates as of which information is given, or incorporated by reference,
in the Registration Statement, the Disclosure Package and the Prospectus, except
as otherwise stated therein, there has not been (i) any material adverse change,
or development involving a prospective material adverse change (including,
whether or not insured against, any loss or damage to any assets that would
constitute a material adverse change), in the Business Conditions of the
Company; (ii) any material adverse change, loss, reduction, termination or
non-renewal of any material contract to which the Company or any Subsidiary is a
party; (iii) any transaction entered into by the Company or any of the
Subsidiaries not in the ordinary course of its business that is material to the
Company or any Subsidiary; (iv) any dividend or distribution of any kind
declared, paid or made by the Company on its capital stock, except for and to
the extent described in the Registration Statement, the Disclosure Package and
the Prospectus; (v) any liabilities or obligations, direct or indirect, incurred
by the Company or any of the Subsidiaries that are material to the Company or
any Subsidiary; (vi) except for purchases of Common Shares by the Company
Dividend Reinvestment Plan, any change in the capitalization of the Company or
any of the Subsidiaries; or (vii) any change in the indebtedness of the Company
or any of its Subsidiaries that is material to the Company or any
Subsidiary. Neither the Company nor any of the Subsidiaries has any
contingent liabilities or obligations that are material and that are not
expressly disclosed in the Registration Statement, the Disclosure Package and
the Prospectus.
(w) Neither
the Company nor any of its officers, directors or affiliates has (i) taken, nor
shall the Company or such persons take, directly or indirectly, any action
designed to, or that might be reasonably expected to, cause or result in
stabilization or manipulation of the price of the Common Shares, or (ii) since
the filing of the Registration Statement (A) sold, bid for, purchased or paid
anyone any compensation for soliciting purchases of, the Shares or (B) paid or
agreed to pay to any person any compensation for soliciting another to purchase
any other securities of the Company.
(x) The
Company and the Subsidiaries have filed with the appropriate federal, state and
local governmental agencies, and all foreign countries and political
subdivisions thereof, all tax returns that are required to be filed or have duly
obtained extensions of time for the filing thereof and have paid all taxes shown
on such returns or otherwise due and all material assessments received by them
to the extent that the same have become due. Neither the Company nor
any of the Subsidiaries has executed or filed with any taxing authority, foreign
or domestic, any agreement extending the period for assessment or collection of
any income or other tax and none of them is a party to any pending action or
proceeding by any foreign or domestic governmental agency for the assessment or
collection of taxes, and no claims for assessment or collection of taxes have
been asserted against the Company or any of the Subsidiaries that might
materially adversely affect the Business Conditions of the Company or any of the
Subsidiaries.
(y) ParenteBeard
LLC, which has given its report on certain financial statements included as part
of, or incorporated by reference in, the Registration Statement, the Disclosure
Package and the Prospectus, is a firm of independent certified public
accountants as required by the Act and the Regulations with respect to the
Company.
9
(z) Neither
the Company nor any of the Subsidiaries is in violation of, or in default under,
any of the terms or provisions of (i) its charter documents or Bylaws or similar
governing instruments and (ii) except where any such default would not
reasonably be expected to have a material adverse effect on the Business
Conditions of the Company or any of the Subsidiaries, (A) any indenture,
mortgage, deed of trust, contract, commitment or other agreement or instrument
to which it is a party or by which it or any of its assets or properties is
bound or affected, (B) any law, rule, regulation, judgment, order or decree of
any government or governmental agency, instrumentality or court, domestic or
foreign, having jurisdiction over it or any of its properties or business, or
(C) any license, permit, certification, registration, approval, consent or
franchise.
(aa) Except as
expressly disclosed in the Registration Statement, the Disclosure Package and
the Prospectus, there are no claims, actions, suits, protests, proceedings,
arbitrations, investigations or inquiries pending before, or, to the Company’s
knowledge, threatened or contemplated by, any governmental agency,
instrumentality, court or tribunal, domestic or foreign, or before any private
arbitration tribunal to which the Company or any of the Subsidiaries is or may
be made a party that could reasonably be expected to affect the validity of any
of the outstanding Common Shares, or that, if determined adversely to the
Company or any of the Subsidiaries would, in any case or in the aggregate,
result in any material adverse change in the Business Conditions of the Company
or any of the Subsidiaries, nor to the Company’s knowledge is there any
reasonable basis for any such claim, action, suit, protest, proceeding,
arbitration, investigation or inquiry. Except as expressly disclosed
in the Registration Statement, the Disclosure Package and the Prospectus, there
are no outstanding orders, judgments or decrees of any court, governmental
agency, instrumentality or other tribunal enjoining the Company or any of the
Subsidiaries from, or requiring the Company or any of the Subsidiaries to take
or refrain from taking, any action, or to which the Company or any of the
Subsidiaries or their properties, assets or businesses are bound or
subject.
(bb) Each of
the Company and the Subsidiaries own, or possess adequate rights to use, all
patents, patent applications, trademarks, trademark registrations, applications
for trademark registration, trade names, service marks, licenses, inventions,
copyrights, know-how (including any unpatented and/or unpatentable proprietary
or confidential technology, information, systems, design methodologies and
devices or procedures developed or derived from or for the Company’s or the
Subsidiaries’ business), trade secrets, confidential information, processes and
formulations and other proprietary information necessary for, used in, or
proposed to be used in, the conduct of the business of the Company and the
Subsidiaries as described in the Registration Statement, the Disclosure Package
and the Prospectus (collectively, the “Intellectual Property”). To
the Company’s knowledge, neither the Company nor any of the Subsidiaries has
infringed, is infringing or has received any notice of conflict with, the
asserted rights of others with respect to the Intellectual Property that,
individually or in the aggregate, if the subject of an unfavorable decision,
ruling or finding, could materially adversely affect the Business Conditions of
the Company or any of the Subsidiaries. To the knowledge of the
Company, no other parties have infringed upon or are in conflict with any
Intellectual Property. Neither the Company nor any of the
Subsidiaries is a party to, or bound by, any agreement pursuant to which
royalties, honorariums or fees are payable by the Company or any of the
Subsidiaries to any person by reason of the ownership or use of any Intellectual
Property, except for such royalties, honorariums or fees associated with
commercially available software and computer applications.
10
(cc) Each of
the Company and the Subsidiaries has good and marketable title to all property
described in the Registration Statement, the Disclosure Package and the
Prospectus as being owned by it, free and clear of all liens, security
interests, charges or encumbrances and the like, except such as are expressly
described or referred to in the Registration Statement, the Disclosure Package
or the Prospectus or such as do not materially adversely affect the Business
Conditions or the conduct of the business of the Company and the Subsidiaries as
described in the Registration Statement, the Disclosure Package and the
Prospectus. Each of the Company and the Subsidiaries has insured its
property against loss or damage by fire or other casualty, in amounts reasonably
believed by the Company to be adequate, and maintains insurance against such
other risks as management of the Company deems appropriate. All real
and personal property leased by the Company and the Subsidiaries, as described
or referred to in the Registration Statement, the Disclosure Package and the
Prospectus, is held by the Company or the Subsidiaries, as applicable, under
valid and enforceable leases. The executive offices and facilities of
the Company and the Subsidiaries (the “Premises”), and all operations presently
or formerly conducted thereon by the Company and the Subsidiaries or any
predecessors thereof, are now and, since the Company and the Subsidiaries began
to use such Premises, always have been and, to the knowledge of the
Company prior to when the Company or the Subsidiaries began to use such
Premises, always had been in compliance with all federal, state and local
statutes, ordinances, regulations, rules, standards and requirements of common
law concerning or relating to industrial hygiene and the protection of health
and the environment (collectively, the “Environmental Laws”), except to the
extent that any failure in such compliance would not materially adversely affect
the Business Conditions of the Company and the Subsidiaries. To the
knowledge of the Company, the facilities of the Company and the Subsidiaries
produce water of sufficient quality and quantity to supply the current and
planned customers and service areas of the Company and the Subsidiaries, and are
not subject to any restriction on groundwater withdrawal under any federal,
state or local law, regulation, rule, order or permit, except as expressly
described in the Registration Statement, the Disclosure Package and the
Prospectus or as provided in States of Delaware and New Jersey or the
Commonwealth of Pennsylvania and other regulatory agencies’ allocation permits
and such as do not materially adversely affect the Business Conditions or the
conduct of the business of the Company and the Subsidiaries as described in the
Registration Statement, the Disclosure Package and the Prospectus. To
the knowledge of the Company, there are no conditions on, about, beneath or
arising from the Premises, in close proximity to the Premises or at any other
location that (i) might give rise to liability, the imposition of a statutory
lien upon the Company or any of the Subsidiaries, (ii) require a “Response,”
“Removal” or “Remedial Action,” as defined herein, under any of the
Environmental Laws by the Company or any of the Subsidiaries or (iii) affect the
quality of the groundwater withdrawn by the Company or the Subsidiaries, and
that in any such case described in (i), (ii) or (iii) would materially adversely
affect the Business Conditions of the Company, except as described in the
Registration Statement, the Disclosure Package or the
Prospectus. Except as expressly disclosed in the Registration
Statement, the Disclosure Package or the Prospectus, or which will not
materially adversely affect the Business Conditions of the Company or the
Subsidiaries, (i) neither the Company nor the Subsidiaries has received notice
or has knowledge of any claim, demand, investigation, regulatory action, suit or
other action instituted or threatened against the Company or any of the
Subsidiaries or any portion of the Premises or any parcel in close proximity to
the Premises relating to any of the Environmental Laws, and (ii) neither
the Company nor any of the Subsidiaries has received any notice of material
violation, citation, complaint, order, directive, request for information or
response thereto, notice letter, demand letter or compliance schedule to or from
any governmental or regulatory agency arising out of or in connection with
“hazardous substances” (as defined by applicable Environmental Laws) on, about,
beneath, arising from or generated at the Premises, near the Premises or at any
other location. As used in this subsection, the terms “Response,”
“Removal” and “Remedial Action” shall have the respective meanings assigned to
such terms under Sections 101(23)-101(25) of the Comprehensive Environmental
Response, Compensation and Liability Act, as amended by the Superfund Amendments
and Reauthorization Act, 42 U.S.C. 9601(23)-9601(25).
11
(dd) Each of
the Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurances that: (i)
transactions are executed in accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary in order to permit
preparation of financial statements in accordance with generally accepted
accounting principles and to maintain accountability for assets; (iii) access to
assets is permitted only in accordance with management’s general or specific
authorization; and (iv) the recorded accountability for assets is compared with
existing assets at reasonable intervals and appropriate action is taken with
respect to any differences.
(ee) The
Company is in compliance in all material respects with all currently effective
provisions of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations
promulgated thereunder that are applicable, or will be applicable as of the
Closing Date, to the Company.
(ff) The
Company, the Subsidiaries and any Related Employer (which for purposes of this
Paragraph means any entity that with the Company or any of the Subsidiaries is a
member of a controlled group of corporations within the meaning of Section
414(b) of the Internal Revenue Code of 1986, as amended (the “Code”), is,
individually or collectively, a trade or business under common control within
the meaning of Section 414(c) of the Code, or is a member of the same affiliated
service group within the meaning of Section 414(m) of the Code) have
established, maintain, contribute to, are required to contribute to, are a party
to, or are bound by certain pension, retirement, profit-sharing plans, deferred
compensation, bonus, or other incentive plans, or medical, vision, dental, or
other health plans, or life insurance or disability plans, or any other employee
benefit plans, programs, arrangements, agreements, or understandings, some of
which are subject to the Employee Retirement Income Security Act of 1974, as
amended (“ERISA”) and the rules and regulations thereunder
(“Plans”). Any disclosure regarding the Plans required under the Act
or the Exchange Act has been made in the Registration Statement, the Disclosure
Package or the Prospectus and the documents incorporated therein. All
Plans that are subject to ERISA are in compliance with ERISA, in all material
respects, and, to the extent a Plan is intended to be tax-qualified within the
meaning of Section 401(a) of the Code, such Plan is in compliance with the Code
in all material respects and is the subject of a current favorable determination
letter from the Internal Revenue Service as to its tax
qualification. No Plan is an employee pension benefit plan that is
subject to Part 3 of Subtitle B of Title I of ERISA, a defined benefit plan
subject to Title IV of ERISA, or a multiemployer plan. None of the
Company, the Subsidiaries or any Related Employer maintains or has maintained
retiree life or retiree health insurance plans that are employee welfare benefit
plans providing for continuing benefit or coverage for any employee or any
beneficiary of any employee after such employee’s termination of employment,
except as required by Section 4980B of the Code and except as disclosed in the
Registration Statement, the Disclosure Package or the Prospectus. No
fiduciary or other party in interest with respect to any of the Plans has caused
any of such Plans to engage in a prohibited transaction as defined in Section
406 of ERISA and Section 4975 of the Code. As used in this
subsection, the terms “defined benefit plan,” “employee benefit plan,” “employee
pension benefit plan,” “employee welfare benefit plan,” “fiduciary” and
“multiemployer plan” shall have the respective meanings assigned to such terms
in Section 3 of ERISA.
12
(gg) No labor
dispute exists with the Company’s or the Subsidiaries’ employees, and to the
Company’s knowledge, no such labor dispute is threatened. The Company
has no knowledge of any existing or threatened labor disturbance by the
employees of any of the principal suppliers, contractors or customers of the
Company or the Subsidiaries that would materially adversely affect the Business
Conditions of the Company or any of the Subsidiaries. None of the
Company’s or the Subsidiaries’ employees is covered by a collective bargaining
agreement and no union organizing activity exists with respect to any of such
employees.
(hh) There are
no contracts, agreements or understandings between the Company or any of the
Subsidiaries and/or any person that would give rise to a valid claim against the
Company or any of the Subsidiaries and/or any Underwriter for a brokerage
commission, finder’s fee or other like payment in connection with the
transactions contemplated herein, the Registration Statement, the Disclosure
Package and the Prospectus, or in any contracts, agreements, understandings,
payments, arrangements or issuances with respect to the Company or any of its
officers, directors, stockholders, employees or affiliates that may affect any
Underwriter’s compensation as determined by FINRA.
(ii) The
Company is not, and after giving effect to the offering and sale of the Shares
and the application of the proceeds therefor described in the Registration
Statement, the Disclosure Package and the Prospectus will not be an “investment
company” or an entity “controlled” by an “investment company,” as such terms are
defined in the Investment Company Act of 1940, as amended. None of
the Subsidiaries is an “investment company” as defined in the Investment Company
Act of 1940, as amended.
(jj) (i) The
Company and the Subsidiaries have received all permits, licenses, franchises,
authorizations, registrations, qualifications and approvals (collectively,
“Permits”) of governmental or regulatory authorities as may be required to own
their properties and conduct their businesses in the manner described in the
Registration Statement, the Disclosure Package and the Prospectus, subject to
such qualifications as may be set forth in the Registration Statement, the
Disclosure Package and the Prospectus; (ii) the Company and the Subsidiaries
have fulfilled and performed all of their material obligations with respect to
such Permits, and no event has occurred which allows or, after notice or lapse
of time or both, would allow revocation or termination thereof or result in any
other material impairment of the rights of the holder of any such Permit,
subject in each case to such qualifications as may be set forth in the
Registration Statement, the Disclosure Package and the Prospectus; and (iii)
except as described in the Registration Statement, the Disclosure Package and
the Prospectus, such Permits contain no restrictions that materially affect the
ability of the Company or the Subsidiaries to conduct their
businesses.
13
(kk)
No
statement, representation, warranty or covenant made by the Company or any of
the Subsidiaries in this Agreement or in any certificate or document required by
this Agreement to be delivered to the Representatives is, or as of the Closing
Date or any Option Closing Date will be, inaccurate, untrue or incorrect in any
material respect. No transaction has occurred or is proposed between
or among the Company or any of the Subsidiaries and any of their respective
officers, directors or stockholders or any affiliate of the foregoing, that is
required to be described in and is not described in the Registration Statement,
the Disclosure Package or the Prospectus.
(ll) None of
the Company, the Subsidiaries or any officer, director, employee, partner, agent
or other person acting on behalf of the Company or the Subsidiaries has,
directly or indirectly, given or agreed to give any money, property or similar
benefit or consideration to any customer or supplier (including any employee or
agent of any customer or supplier) or official or employee of any agency or
instrumentality of any government (foreign or domestic) or political party or
candidate for office (foreign or domestic) or any other person who was, is or in
the future may be in a position to affect the Business Conditions of the Company
or any of the Subsidiaries or any actual or proposed business transaction of the
Company or any of the Subsidiaries that (i) could subject the Company or any of
the Subsidiaries to any liability (including, but not limited to, the payment of
monetary damages) or penalty in any civil, criminal or governmental action or
proceeding that would have a material adverse effect on the Business Conditions
of the Company or any of the Subsidiaries or (ii) with respect to the Company,
the Subsidiaries, or any officer or director thereof, violates any law, rule or
regulation to which the Company or any of the Subsidiaries is
subject.
(mm) The
Company’s board of directors has validly appointed an audit committee whose
composition satisfies the requirements of the Exchange Act, the rules and
regulations of the SEC adopted thereunder and the rules of FINRA that are
applicable as of the Closing Date. The Company’s audit committee has
adopted a charter that satisfies the Exchange Act, the rules and regulations of
the SEC adopted thereunder and the rules of FINRA that are applicable as of the
Closing Date.
(nn) At the
time of filing the Registration Statement and as of the date of the execution
and delivery of this Agreement (with such date being used as the determination
date for purposes hereof), the Company was not and is not an Ineligible Issuer
(as defined in Rule 405 of the Act), without taking account of any determination
by the SEC pursuant to Rule 405 of the Act that it is not necessary that the
Company be considered an Ineligible Issuer.
(oo) Any
certificate signed by any officer of the Company or any of the Subsidiaries in
such capacity and delivered to the Representatives or to counsel for the
Underwriters pursuant to this Agreement shall be deemed a representation and
warranty by the Company or the Subsidiaries as the case may be, to each
Underwriter as to the matters covered thereby.
14
2. Purchase and Sale of Firm
Shares. On the basis of
the representations, warranties, covenants and agreements contained herein, but
subject to the terms and conditions set forth herein, the Company shall sell the
Firm Shares to the several Underwriters at the Offering Price less the
Underwriting Discounts and Commissions shown on the cover page of the
Prospectus, and the Underwriters, severally and not jointly, shall purchase from
the Company on a firm commitment basis, at the Offering Price less the
Underwriting Discounts and Commissions shown on the cover page of the
Prospectus, the respective amounts of the Firm Shares set forth opposite their
names on Schedule I
hereto. In making this Agreement, each Underwriter is contracting
severally and not jointly, and except as provided in Sections 4 and 12 hereof,
the agreement of each Underwriter is to purchase only that number of Shares
specified with respect to that Underwriter in Schedule I
hereto. The Underwriters shall offer the Shares to the public as set
forth in the Prospectus.
3. Payment and
Delivery. The Firm Shares
shall be issued in the form of one or more fully registered global securities
(the “Global Securities”) in book-entry form in such denominations and
registered in the name of the nominee of The Depository Trust Company (“DTC”) or
in such names as the Representatives may request upon at least 48 hours’ prior
notice to the Company and shall be delivered by or on behalf of the Company to
the Representatives for the account of such Underwriter against payment by such
Underwriter on its behalf of the purchase price therefor by wire transfer of
immediately available funds to such accounts as the Company shall designate in
writing (with all costs and expenses incurred by the Underwriters in connection
with such settlement in immediately available funds, including, but not limited
to, interest or cost of funds and expenses, to be borne by the
Company). The closing of the sale and purchase of the Firm Shares
shall be held at the offices of Xxxxxxx Xxxxx LLP, 0000 Xxxxxx Xxxxxx,
Xxxxxxxxxxxx, Xxxxxxxxxxxx for the respective accounts of the
Underwriters. Such payment and delivery will be made at
10:00 a.m., Philadelphia, Pennsylvania time, on the third business day
after the date of this Agreement, or at such other time on the same or such
other date, not later than seven business days thereafter as shall be designated
in writing by the Representatives. Such time and date are referred to
herein as the “Closing Date.” The Company shall make the Global
Securities representing the Firm Shares available for examination by the
Representatives and counsel for the Underwriters at the Philadelphia
correspondent office of the Company’s transfer agent not less than one full
business day prior to the Closing Date.
4. Option to Purchase Optional
Shares.
(a) For the
purposes of covering any over-allotments in connection with the distribution and
sale of the Firm Shares as contemplated by the Prospectus, subject to the terms
and conditions herein set forth, the several Underwriters are hereby granted an
option by the Company to purchase all or any part of the Optional Shares (the
“Over-allotment Option”). The purchase price to be paid for the
Optional Shares shall be the Offering Price less the Underwriting Discounts and
Commissions shown on the cover page of the Prospectus. The
Over-allotment Option granted hereby may be exercised by the Representatives on
behalf of the several Underwriters as to all or any part of the Optional Shares
at any time and from time to time within 30 days after the date of the
Prospectus. No Underwriter shall be under any obligation to purchase
any Optional Shares prior to an exercise of the Over-allotment
Option.
15
(b) The
Over-allotment Option granted hereby may be exercised by the Representatives on
behalf of the several Underwriters by giving notice to the Company by a letter
sent by registered or certified mail, postage prepaid, telex, telegraph,
telegram or facsimile (such notice to be effective when received), addressed as
provided in Section 14 hereof, setting forth the number of Optional Shares
to be purchased, the date and time for delivery of and payment for the Optional
Shares and stating that the Optional Shares referred to therein are to be used
for the purpose of covering over-allotments in connection with the distribution
and sale of the Firm Shares. If such notice is given at least two
full business days prior to the Closing Date, the date set forth therein for
such delivery and payment shall be not earlier than the Closing
Date. If such notice is given after two full business days prior to
the Closing Date, the date set forth therein for such delivery and payment shall
be a date selected by the Representatives not later than five full business days
after the exercise of the Over-allotment Option. The date and time
set forth in such a notice is referred to herein as an “Option Closing Date,”
and a closing held pursuant to such a notice is referred to herein as an “Option
Closing.” Upon each exercise of the Over-allotment Option, and on the
basis of the representations, warranties, covenants and agreements herein
contained, and subject to the terms and conditions herein set forth, the several
Underwriters shall become severally, but not jointly, obligated to purchase from
the Company the number of Optional Shares specified in each notice of exercise
of the Over-allotment Option (allocated among them in accordance with Section
4(c) hereof).
(c) The
number of Optional Shares to be purchased by each Underwriter pursuant to each
exercise of the Over-allotment Option shall be the number that bears the same
ratio to the aggregate number of Optional Shares being purchased through such
Over-allotment Option exercise as the number of Firm Shares opposite the name of
such Underwriter in Schedule I
hereto bears to the total number of all Firm Shares. Notwithstanding
the foregoing, the number of Optional Shares purchased and sold pursuant to each
exercise of the Over-allotment Option shall be subject to such adjustment as the
Representatives may approve to eliminate fractional shares and subject to the
provisions for the allocation of Optional Shares purchased for the purpose of
covering over-allotments set forth in the agreement entered into by and among
the Underwriters in connection herewith (the “Agreement Among
Underwriters”).
(d) The
Optional Shares shall be issued in the form of one or more Global Securities in
book-entry form in such denominations and registered in the name of the nominee
of DTC or in such names as the Representatives may request upon at least 48
hours’ prior notice to the Company, and shall be delivered by or on behalf of
the Company to the Representatives for the account of such Underwriter, against
payment by such Underwriter on its behalf of the purchase price therefor by wire
transfer of immediately available funds to such accounts as the Company shall
designate in writing (with all costs and expenses incurred by the Underwriters
in connection with such settlement in immediately available funds, including,
but not limited to, interest or cost of funds and expenses, to be borne by the
Company). The closing of the sale and purchase of the Optional Shares
shall be held at the offices of Xxxxxxx Xxxxx LLP, 0000 Xxxxxx Xxxxxx,
Xxxxxxxxxxxx, Xxxxxxxxxxxx for the respective accounts of the
Underwriters. Such payment and delivery will be made at 10:00 a.m.,
Philadelphia, Pennsylvania time, on the Option Closing Date. The
Company shall make the Global Securities representing the Optional Shares
available for examination by the Representatives and counsel for the
Underwriters at the Philadelphia correspondent office of the Company’s transfer
agent not less than one full business day prior to the Option Closing
Date.
16
5. Certain Covenants and
Agreements of the Company. The
Company covenants and agrees with the several Underwriters as
follows:
(a) The
Company will comply with the requirements of Rule 430B.
(b)
The
Company will not file with the SEC, the Prospectus, any amendment or supplement
to the Prospectus or any amendment to the Registration Statement or the
Disclosure Package, and will not use, authorize, refer to or file any Issuer
Free Writing Prospectus, unless the Representatives have received a reasonable
period of time to review any such proposed amendment, supplement or Issuer Free
Writing Prospectus and consented to the filings thereof, and will use its best
efforts to cause any such amendment to the Registration Statement to be declared
effective as promptly as possible. Upon reasonable request of the
Representatives or counsel for the Underwriters, the Company will promptly
prepare and file with the SEC, in accordance with the Regulations, any
amendments to the Registration Statement or amendments or supplements to the
Prospectus or the Disclosure Package that may be necessary or advisable in
connection with the distribution of the Shares by the several Underwriters and
will use its best efforts to cause any such amendment to the Registration
Statement to be declared effective as promptly as possible. If
required, the Company will file any amendment or supplement to the Prospectus or
the Disclosure Package with the SEC in the manner and within the time period
required by Rule 424(b) or Rule 433 under the Act. The Company will
advise the Representatives, promptly after receiving notice thereof, of the time
when the Registration Statement or any amendment thereof has been filed or
declared effective or the Prospectus or the Disclosure Package, or any amendment
or supplement thereto has been filed and will provide evidence to the
Representatives of each filing or effectiveness.
(c) The
Company will advise the Representatives immediately, and confirm such advice in
writing, (i) when any post-effective amendment to the Registration Statement is
filed with the SEC under Rule 462(c) under the Act or otherwise, (ii) when any
Rule 462(b) Registration Statement is filed, (iii) of the receipt of any
comments from the SEC concerning the Registration Statement, (iv) when any
post-effective amendment to the Registration Statement becomes effective, or
when any supplement to the Prospectus or the Disclosure Package or any amended
Prospectus or Disclosure Package has been filed, (v) of any request of the SEC
for amendment or supplementation of the Registration Statement, the Disclosure
Package or the Prospectus or for additional information, (vi) during the period
when a prospectus is required to be delivered under the Act and Regulations (the
“Prospectus Delivery Period”), of the happening of any event as a result of
which any Prospectus would include an untrue statement of a material fact or
omit to state a material fact necessary to make the statements therein not
misleading, (vii) during the Prospectus Delivery Period, of the need to amend
the Registration Statement or supplement the Prospectus to comply with the Act,
(viii) of the issuance by the SEC of any stop order suspending the effectiveness
of the Registration Statement or of any order preventing or suspending the use
of any Preliminary Prospectus or the Prospectus, and (ix) of the suspension of
the approval of the Shares for listing on Nasdaq or the qualification of any of
the Shares for offering or sale in any jurisdiction in which the Underwriters
intend to make such offers or sales, or the initiation or threatening of any
proceedings for any of such purposes known to the Company. The
Company will use its best efforts to prevent the issuance of any such stop order
or of any order preventing or suspending such use, and if any such order is
issued, to obtain as soon as possible the lifting thereof.
17
(d) The
Company has delivered to the Representatives, without charge, as many copies of
each Preliminary Prospectus as the Representatives have reasonably
requested. The Company will deliver, without charge, to the
Representatives, such number of copies of the Registration Statement, the
Disclosure Package and the Prospectus, and any supplements or amendments
thereto, as the Representatives may reasonably request from time to time during
the Prospectus Delivery Period. The Company hereby consents to the
use of such copies of the Disclosure Package and the Prospectus for purposes
permitted by the Act, the Regulations and the securities or Blue Sky laws of the
states or foreign jurisdictions in which the Shares are offered by the several
Underwriters and by all dealers to whom Shares may be sold, both in connection
with the offering and sale of the Shares and during the Prospectus Delivery
Period. The Company has furnished or will furnish to the
Representatives at least one original signed copy of the Registration Statement
as originally filed and of all amendments and supplements thereto, whether filed
before or after the Effective Time, at least one copy of all exhibits filed
therewith and of all consents and certificates of experts, and will deliver to
the Representatives such number of conformed copies of the Registration
Statement, including financial statements and exhibits, and all amendments
thereto, as the Representatives may reasonably request.
(e) The
Company will comply with the Act, the Regulations, the Exchange Act and the
rules and regulations thereunder so as to permit the continuation of sales of
and dealings in the Shares for as long as may be necessary to complete the
distribution of the Shares as contemplated hereby.
(f) The
Company will furnish such information and pay such filing fees and other
expenses as may be required, including its counsel’s reasonable legal fees, and
otherwise cooperate in the registration or qualification of the Shares, or
exemption therefrom, for offering and sale by the several Underwriters and by
dealers under the securities or Blue Sky laws of such jurisdictions in which the
Representatives determine to offer the Shares, after consultation with the
Company, and will file such consents to service of process or other documents
necessary or appropriate in order to effect such registration or qualification;
provided, however, that no such qualification shall be required in any
jurisdiction where, solely as a result thereof, the Company would be subject to
taxation or qualification as a foreign corporation doing business in such
jurisdiction where it is not now so qualified or to take any action which would
subject it to service of process in suits, other than those arising out of the
offering or sale of the Shares, in any jurisdiction where it is not now so
subject. The Company will, from time to time, prepare and file such
statements and reports as are or may be required to continue such qualification
in effect for so long a period as is required under the laws of such
jurisdictions for such offering and sale. The Company will furnish
such information and pay such filing fees and other expenses as may be required,
and otherwise cooperate in the listing of the Shares on Nasdaq. The
Company will, from time to time, prepare and file such statements and reports as
are or may be required to continue such qualification in effect for a period of
three years from the Effective Time.
18
(g) Subject
to Section 5(b) hereof, in case of any event occurring at any time within the
Prospectus Delivery Period, as a result of which the Disclosure Package or the
Prospectus, as then amended or supplemented, would contain, in the opinion of
counsel for the Underwriters, an untrue statement of a material fact, or omit to
state any material fact necessary in order to make the statements therein not
misleading, or, if it is necessary at any time to amend the Disclosure Package
or the Prospectus to comply with the Act or the Regulations or any applicable
securities or Blue Sky laws, the Company promptly will prepare and file with the
SEC, and any applicable state and foreign securities commission, an amendment,
supplement or document that will correct such statement or omission or effect
such compliance and will furnish to the several Underwriters such number of
copies of such amendments, supplements or documents (in form and substance
satisfactory to the Representatives and counsel for the Underwriters) as the
Representatives may reasonably request. For purposes of this Section
5(g), the Company will provide such information to the Representatives, the
Underwriters’ counsel and counsel to the Company as shall be necessary to enable
such persons to consult with the Company with respect to the need to amend or
supplement the Registration Statement, the Disclosure Package or the Prospectus
or file any document, and shall furnish to the Representatives and the
Underwriters’ counsel such further information as each may from time to time
reasonably request.
(h) The
Company agrees that, unless it obtains the prior written consent of the
Representatives, it will not make any offer relating to the Shares that would
constitute an Issuer Free Writing Prospectus or that would otherwise constitute
a “free writing prospectus” (as defined in Rule 405 of the Act) required to be
filed by the Company with the SEC or retained by the Company under Rule 433 of
the Act; provided that the prior written consent of the Representatives shall be
deemed to have been given in respect of the free writing prospectuses included
in Schedule II
hereto. Any such free writing prospectus consented to by the
Representatives is hereinafter referred to as a “Permitted Free Writing
Prospectus.” The Company agrees that (i) it has treated and will
treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer
Free Writing Prospectus, and (ii) has complied and will comply, as the case may
be, with the requirements of Rules 164 and 433 of the Act applicable to any
Permitted Free Writing Prospectus, including in respect of timely filing with
the SEC, legending and record keeping.
(i) The
Company will make generally available to its security holders and the
Representatives as soon as practicable an earnings statement of the Company that
satisfies the provisions of Section 11(a) of the Act and Rule 158
promulgated thereunder covering a period of at least twelve months beginning
with the Company’s first fiscal quarter occurring after the “effective date” (as
defined in Rule 158) of the Registration Statement.
(j) Prior to
the Closing Date, the Company will issue no press release or other
communications directly or indirectly and hold no press conference with respect
to the Company or its Subsidiaries, the condition, financial or otherwise, or
the earnings, business, operations or prospects of any of them, or the offering
of the Shares without the prior written consent of the Representatives unless in
the judgment of the Company and its counsel, and after notification to the
Representatives such press release or communication is required by
law.
19
(k) For a
period of three years from the date hereof, the Company will deliver to the
Representatives and, upon request, to each of the Underwriters: (i) a
copy of each report or document, including, without limitation, reports on Forms
8-K, 10-K and 10-Q (or such similar forms as may be designated by the SEC),
registration statements and any exhibits thereto, filed or furnished to the SEC
or any securities exchange or FINRA, on the date each such report or document is
so filed or furnished; (ii) as soon as practicable, copies of any reports or
communications (financial or other) of the Company mailed to its security
holders; and (iii) every material press release in respect of the Company or its
affairs that is released or prepared by the Company.
(l) During
the course of the distribution of the Shares, the Company and the Subsidiaries
will not, and the Company shall cause its officers and directors not to, (i)
take, directly or indirectly, any action designed to, or that could reasonably
be expected to, cause or result in stabilization or manipulation of the price of
the Common Shares or (ii) sell, bid for, purchase or pay anyone any compensation
for soliciting purchases of, the Shares.
(m) The
Company has caused each person listed on Schedule III hereto
to execute an agreement (a “Lock-up Agreement”) in the form set forth as Exhibit A
hereto. The Company has delivered such agreements to the
Representatives prior to the date of this Agreement. Appropriate stop
transfer instructions will be issued by the Company to the transfer agent for
the Common Shares and a copy of such instructions will be delivered to the
Representatives.
(n) During
the period commencing on the date hereof and ending on the 90th day following
the date of the Prospectus, the Company will not, without the prior written
consent of the Representatives (which consent may be withheld at the sole
discretion of the Representatives), directly or indirectly, sell, offer,
contract or grant any option to sell, pledge, transfer or establish an open “put
equivalent position” within the meaning of Rule 16a-1(h) under the Exchange Act
or liquidate or decrease a “call equivalent position” within the meaning of Rule
16a-1(b) under the Exchange Act, or otherwise dispose of or transfer (or enter
into any transaction which is designed to, or would reasonably be expected to,
result in the disposition of), or announce the offering of, or file any
registration statement under the Act in respect of, any shares of Common Shares,
options or warrants to acquire shares of Common Shares or securities
exchangeable or exercisable for or convertible into shares of Common Shares
(other than as contemplated by this Agreement with respect to the Shares);
provided, however, that the Company may issue Common Shares under the Company’s
Dividend Reinvestment Plan, 401(k) Plan and Restricted Stock
Plan. Notwithstanding the foregoing, if (x) during the last 17 days
of the 90-day restricted period the Company issues an earnings release or
material news or a material event relating to the Company occurs, or (y) prior
to the expiration of the 90-day restricted period, the Company announces that it
will release earnings results during the 16-day period beginning on the last day
of the 90-day period, the restrictions imposed in this clause shall continue to
apply until the expiration of the 18-day period beginning on the issuance of the
earnings release or the occurrence of the material news or material
event. The Company will provide the Representatives with prior notice
of any announcement described in clause (y) of the preceding sentence that gives
rise to an extension of the restricted period.
20
(o) For a
period of three years from the date hereof, the Company will use all reasonable
efforts to maintain the listing of the Common Shares (including, without
limitation, the Shares) on Nasdaq or on another national securities
exchange.
(p) The
Company shall, at its sole cost and expense, supply and deliver to the
Representatives and the Underwriters’ counsel, within a reasonable period from
the Closing Date transaction binders in such number and in such form and content
as the Representatives reasonably request.
(q) The
Company will use the net proceeds from the sale of the Shares to be sold by it
hereunder substantially in accordance with the description set forth in the
Prospectus.
6. Certain Covenants and
Agreement of the Underwriters. The
Underwriters agree that, unless the Representatives obtain the prior written
consent of the Company, they will not make any offer relating to the Shares that
would constitute a “free writing prospectus” (as defined in Rule 405 of the Act)
required to be filed by the Company with the SEC or retained by the Company
under Rule 433 of the Act; provided that the prior written consent of the
Company shall be deemed to have been given in respect of the free writing
prospectuses included in Schedule II
hereto. Any such free writing prospectus consented to by the Company
is hereinafter deemed to be a Permitted Free Writing Prospectus.
7. Payment
of Fees and Expenses.
(a) Whether
or not the transactions contemplated by this Agreement are consummated and
regardless of the reason this Agreement is terminated, the Company will pay or
cause to be paid, and bear or cause to be borne, all costs and expenses incident
to the performance of the obligations of the Company under this Agreement,
including: (i) the fees and expenses of the accountants and counsel
for the Company incurred in the preparation of the Registration Statement and
any post-effective amendments thereto (including financial statements and
exhibits), the Disclosure Package, any Preliminary Prospectuses and the
Prospectus and any amendments or supplements thereto; (ii) printing and mailing
expenses associated with the Registration Statement and any post-effective
amendments thereto, the Disclosure Package, any Preliminary Prospectus, the
Prospectus, this Agreement, the Agreement Among Underwriters, the Underwriters’
Questionnaire, the power of attorney executed by each of the Underwriters, the
Selected Dealer Agreement and any related documents and any Blue Sky memorandum
(and any supplement thereto); (iii) the costs and expenses (other than fees and
expenses of the Underwriters’ counsel) incident to the authentication, issuance,
sale and delivery of the Shares to the Underwriters; (iv) the fees, expenses and
all other costs of qualifying the Shares for sale under the securities or Blue
Sky laws of those states or foreign jurisdictions in which the Shares are to be
offered or sold (other than fees and expenses of Underwriters’ counsel); (v) the
fees, expenses and other costs of, or incident to, securing any review or
approvals by or from FINRA, (other than fees and expenses of the Underwriters’
counsel), (vi) the filing fees of the SEC; (vii) the cost of furnishing to the
Underwriters copies of the Registration Statement, the Disclosure Package, any
Preliminary Prospectuses and Prospectuses as herein provided; (viii) the
Company’s travel expenses in connection with meetings with the brokerage
community and institutional investors; (ix) the costs and expenses associated
with settlement in same day funds (including, but not limited to, interest or
cost of funds expenses), if desired by the Company; (x) any fees or costs
payable to Nasdaq as a result of the offering; (xi) the cost of preparing,
issuing and delivery to the Underwriters of any certificates evidencing the
Shares; (xii) the costs and charges of any transfer agent; (xiii) the reasonable
costs of advertising the offering provided the same are approved in advance by
the Company; (xiv) all taxes, if any, on the issuance, delivery and transfer of
the Shares sold by the Company; and (xv) all other costs and expenses reasonably
incident to the performance of the Company’s obligations hereunder that are not
otherwise specifically provided for in this Section 7(a); provided, however,
that, except as specifically set forth in Section 7(c) hereof, the Underwriters
shall be responsible for their out-of-pocket expenses, including those
associated with meetings with the brokerage community and institutional
investors, other than the Company’s travel expenses, and the fees and expenses
of their counsel.
21
(b) On the
Closing Date, the Company shall pay the Representatives a non-accountable
expense allowance in the amount of $50,000.
(c) If (i)
the Underwriters are willing to proceed with the Offering, and the transactions
contemplated by this Agreement are not consummated because the Company elects
not to proceed with the offering for any reason or (ii) the Representatives
terminate this Agreement pursuant to Section 11(b)(i) hereof, then the Company
will reimburse the Underwriters for their incurred reasonable out-of-pocket
expenses relating to the Offering (including but not limited to the reasonable
fees and disbursements to their counsel), which reimbursement shall not exceed
$150,000. The Representatives shall present a reasonable accounting
of all expenses for which reimbursement is claimed hereunder.
8. Conditions of Underwriters’
Obligations. The
obligation of each Underwriter to purchase and pay for the Firm Shares that it
has agreed to purchase hereunder on the Closing Date, and to purchase and pay
for any Optional Shares as to which it exercises its right to purchase under
Section 4 on an Option Closing Date, is subject at the date hereof, the Closing
Date and any Option Closing Date to the continuing accuracy and fulfillment of
the representations and warranties of the Company, to the performance by the
Company of its covenants and obligations hereunder, and to the following
additional conditions:
(a) The
Preliminary Prospectus and the Prospectus shall have been filed with the SEC
pursuant to Rule 424(b) of the Regulations within the applicable time period
prescribed for such filing by the Regulations. The Company shall have
filed any material required to be filed by the Company with the SEC in the
manner and within the time period required by Rule 433 of the Regulations,
including any Issuer Free Writing Prospectus and any Other Free Writing
Prospectus
(b) If the
Company elects to rely upon Rule 462(b), the Company shall file a Rule 462(b)
Registration Statement with the SEC in compliance with Rule 462(b) by 10:00
P.M., Washington, D.C. time, on the date of this Agreement, and the Company
shall at the time of filing either pay to the SEC the filing fee for the Rule
462(b) Registration Statement or give irrevocable instructions for the payment
of such fee pursuant to Rule 111(b) under the Act.
22
(c) On or
prior to the Closing Date or any Option Closing Date, as the case may be, no
stop order or other order preventing or suspending the effectiveness of the
Registration Statement (including any document incorporated by reference
therein), the 462(b) Registration Statement or any post-effective amendment to
the Registration Statement or the sale of any of the Shares shall have been
issued under the Act or any state or foreign securities law, and no proceedings
for that purpose shall have been initiated or shall be pending or, to the
Representatives’ knowledge or the knowledge of the Company, shall be
contemplated by the SEC or by any authority in any jurisdiction designated by
the Representatives pursuant to Section 5(f) hereof. Any request on
the part of the SEC or any state or foreign securities authority for additional
information shall have been complied with to the reasonable satisfaction of
counsel for the Underwriters.
(d) All
corporate proceedings and other matters incident to the authorization, form and
validity of this Agreement, the Shares and the form of the Registration
Statement, the Disclosure Package and the Prospectus, and all other legal
matters relating to this Agreement and the transactions contemplated hereby
shall be satisfactory in all material respects to counsel for the
Underwriters. The Company shall have furnished to such counsel all
documents and information that they may have reasonably requested to enable them
to pass upon such matters. The Representatives shall have received
from the Underwriters’ counsel, Xxxxxxx Xxxxx LLP, an opinion, dated as of the
Closing Date and any Option Closing Date, as the case may be, and addressed to
the Representatives individually and as representatives of the several
Underwriters, which opinion shall be satisfactory in all respects to the
Representatives.
(e) The
Representatives shall have received a copy of an executed Lock-up Agreement from
the Company and each of the persons listed on Schedule III
hereto.
(f) On the
Closing Date and any Option Closing Date, there shall have been delivered to the
Representatives the opinion of Xxxxxx, XxXxxxxxxx & Xxxxxx, P.A., counsel
for the Company, dated as of each such date and addressed to the Representatives
individually and as representatives of the several Underwriters to the effect
set forth on Exhibit
B or to such effect as is otherwise reasonably satisfactory to the
Representatives.
(g) At the
Closing Date and any Option Closing Date: (i) the Registration
Statement and any post-effective amendment thereto and the Disclosure Package
and the Prospectus and any amendments or supplements thereto shall contain all
statements that are required to be stated therein in accordance with the Act and
the Regulations, and shall conform to the requirements of the Act and the
Regulations in all material respects, and none of the Registration Statement nor
any post-effective amendment thereto, the Disclosure Package or the Prospectus
and any amendments or supplements thereto shall contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading; (ii) since the
respective dates as of which information is given in the Registration Statement
and any post-effective amendment thereto and the Disclosure Package and the
Prospectus and any amendments or supplements thereto, except as otherwise stated
therein, there shall have been no material adverse change in the Business
Conditions of the Company from that set forth therein whether or not arising in
the ordinary course of business; (iii) since the respective dates as of which
information is given in the Registration Statement, the Disclosure Package and
the Prospectus or any amendment or supplement thereto, there shall have been no
event or transaction, contract or agreement entered into by the Company or any
of the Subsidiaries other than in the ordinary course of business and as set
forth in the Registration Statement, the Disclosure Package or the Prospectus,
that has not been, but would be required to be, set forth in the Registration
Statement, the Disclosure Package or Prospectus; (iv) since the respective dates
as of which information is given in the Registration Statement and any
post-effective amendment thereto and the Disclosure Package and the Prospectus
and any amendments or supplements thereto, there shall have been no material
adverse change, loss, reduction, termination or non-renewal of any contract to
which the Company or any of the Subsidiaries is a party, that has not been, but
would be required to be set forth in the Registration Statement, the Disclosure
Package or the Prospectus; and (v) no action, suit or proceeding at law or in
equity shall be pending or threatened against the Company or any of the
Subsidiaries that would be required to be set forth in the Disclosure Package or
the Prospectus, other than as set forth therein, and no proceedings (other than
rate cases filed by the Company or its Subsidiaries) shall be pending or
threatened against or directly affecting the Company or any of the
Subsidiaries before or by any federal, state or other commission,
board or administrative agency wherein an unfavorable decision, ruling or
finding would materially adversely affect the Business Conditions of the
Company.
23
(h) The
Representatives shall have received at the Closing Date and any Option Closing
Date certificates of the Chief Executive Officer and the Chief Financial Officer
of the Company dated as of the date of the Closing Date or Option Closing Date,
as the case may be, and addressed to the Representatives individually and as
representatives of the several Underwriters to the effect that (i) the
representations and warranties of the Company in this Agreement are true and
correct, as if made at and as of the Closing Date or the Option Closing Date, as
the case may be, and that the Company has complied with all the agreements,
fulfilled all the covenants and satisfied all the conditions on its part to be
performed, fulfilled or satisfied at or prior to the Closing Date or the Option
Closing Date, as the case may be, and (ii) the signers of the certificate have
carefully examined the Registration Statement, the Disclosure Package and the
Prospectus and any amendments or supplements thereto, and the conditions set
forth in Section 8 hereof have been satisfied.
(i) At the
time this Agreement is executed and at the Closing Date and any Option Closing
Date, the Representatives shall have received a letter, dated the date of
delivery thereof, from ParenteBeard LLC with respect to the financial statements
and certain financial information of the Company and the Subsidiaries set forth
in or incorporated by reference in the Registration Statement, the Disclosure
Package and the Prospectus, each such letter addressed to the Representatives,
individually and as representatives of the several Underwriters, containing
statements and information of the type ordinarily included in accountants’
“comfort letters” and in form and substance satisfactory to the Representatives
in all respects; provided, that each such letter shall use a “cut-off” date no
more than five business days prior to the date of such letter.
(j) All
corporate and other proceedings and other matters incident to the authorization,
form and validity of this Agreement and the form of the Registration Statement
and Prospectus and all other legal matters related to this Agreement and the
transactions contemplated hereby shall be reasonably satisfactory in all
respects to counsel to the Underwriters. The Company shall have
furnished to such counsel all documents and information that they shall have
reasonably requested to enable them to pass upon such matters.
24
(k) FINRA
shall have confirmed that it has not raised any objection with respect to the
fairness and reasonableness of the underwriting terms and
arrangements.
(l) The
Shares shall have been listed on Nasdaq.
(m) At the
Closing Date and any Option Closing Date, the Representatives shall have been
furnished such additional documents, information and certificates as they shall
have reasonably requested.
All such
opinions, certificates, letters and documents shall be in compliance with the
provisions hereof only if they are reasonably satisfactory in form and substance
to the Representatives and the Underwriters’ counsel. The Company
shall furnish the Representatives with such conformed copies of such opinions,
certificates, letters and other documents as they shall reasonably
request. If any condition to the Underwriters’ obligations hereunder
to be fulfilled prior to or at the Closing Date or any Option Closing Date, as
the case may be, is not fulfilled, the Representatives on behalf of the several
Underwriters may terminate this Agreement with respect to the Closing Date or
such Option Closing Date, as applicable, or, if they so elect, waive any such
conditions which have not been fulfilled or extend the time for their
fulfillment. Any such termination shall be without liability of the
Underwriters to the Company, except that Section 7 and Section 9 shall at all
times be effective and shall survive such termination.
9. Indemnification
and Contribution.
(a) The
Company shall indemnify and hold harmless each Underwriter, and each person, if
any, who controls each Underwriter within the meaning of the Act and the
Exchange Act, against any and all loss, liability, claim, damage and expense
whatsoever, including, but not limited to, any and all reasonable expenses
incurred in investigating, preparing or defending against any litigation,
commenced or threatened, or any claim whatsoever or in connection with any
investigation or inquiry of, or action or proceeding that may be brought
against, the respective indemnified parties, arising out of or based upon any
breach of the Company’s representations and warranties made in this Agreement or
any untrue statements or alleged untrue statements of material fact contained in
the Registration Statement, any Preliminary Prospectus, the Disclosure Package
or the Prospectus, any application or other document filed in any jurisdiction
in order to qualify all or any part of the Shares under the securities laws
thereof or filed with the SEC, FINRA or Nasdaq (in this Section 9
collectively called “application”), or the omission or alleged omission from any
of the foregoing of a material fact required to be stated therein or necessary
to make the statements therein not misleading; provided, however, that the
foregoing indemnity shall not apply in respect of any statement or omission made
in reliance upon and in conformity with written information furnished to the
Company by any Underwriter through the Representatives expressly for use in any
Preliminary Prospectus, the Disclosure Package, the Registration Statement or
Prospectus, or any amendment or supplement thereto, or in any application or in
any communication to the SEC, as the case may be. The obligations of
the Company under this Section 9(a) will be in addition to any liability the
Company may otherwise have.
25
(b) Each
Underwriter severally and not jointly shall indemnify and hold harmless the
Company, each of the directors of the Company, each of the officers of the
Company who shall have signed the Registration Statement, and each other person,
if any, who controls the Company within the meaning of the Act to the same
extent as the foregoing indemnities from the Company to the several
Underwriters, but only with respect to any and all loss, liability, claim,
damage or expense resulting from statements or omissions, or alleged statements
or omissions, if any, made in any Preliminary Prospectus, the Disclosure
Package, the Registration Statement or the Prospectus or any amendment or
supplement thereof or any application or in any communication to the SEC in
reliance upon, and in conformity with written information furnished to the
Company by any Underwriter through the Representatives expressly for use in any
Preliminary Prospectus, the Disclosure Package, the Registration Statement or
the Prospectus or any amendment or supplement thereof, or any application or in
any communication to the SEC, as the case may be. The obligations of
each Underwriter under this Section 9(b) will be in addition to any liability
which such Underwriter may otherwise have.
(c) If any
action, inquiry, investigation or proceeding is brought against any person in
respect of which indemnification may be sought pursuant to Section 9(a) or (b)
hereof, such person (hereinafter called the “indemnified party”) shall, promptly
after notification of, or receipt of service of process for, such action,
inquiry, investigation or proceeding, notify in writing the party or parties
against whom indemnification is to be sought (hereinafter called the
“indemnifying party”) of the institution of such action, inquiry, investigation
or proceeding. The indemnifying party, upon the request of the
indemnified party, shall assume the defense of such action, inquiry,
investigation or proceeding, including, without limitation, the employment of
counsel (reasonably satisfactory to such indemnified party) and payment of
expenses. No indemnification provided for in this Section 9 shall be
available to any indemnified party who shall fail to give such notice if the
indemnifying party does not have knowledge of such action, inquiry,
investigation or proceeding to the extent that such indemnifying party has been
materially prejudiced by the failure to give such notice, but the omission to so
notify the indemnifying party shall not relieve the indemnifying party otherwise
than under this Section 9. Such indemnified party shall have the
right to employ its or their own counsel in any such case, but the fees and
expenses of such counsel shall be at the expense of such indemnified party
unless the employment of such counsel shall have been authorized in writing by
the indemnifying party in connection with the defense of such action or if the
indemnifying party shall not have, within a reasonable period of time in light
of the circumstances, employed counsel reasonably satisfactory to the
indemnified party to be in charge of the defense of such action, inquiry,
investigation or proceeding, or if such indemnified party or parties shall have
been advised by counsel that there may be a conflict between the positions of
the indemnifying party or parties and of the indemnified party or parties or
that there may be legal defenses available to such indemnified party or parties
different from or in addition to those available to the indemnifying party or
parties, in any of which events the indemnified party or parties shall be
entitled to select counsel to conduct the defense to the extent determined by
such counsel to be necessary to protect the interests of the indemnified party
or parties, and the reasonable fees and expenses of such counsel shall be borne
by the indemnifying party. The indemnifying party shall be
responsible for the fees and disbursements of only one such counsel so engaged
by the indemnified party or parties. Expenses covered by the
indemnification in this Section 9, shall be paid by the indemnifying party
as they are incurred by the indemnified party. No indemnifying party
shall, without the prior written consent of the indemnified party, effect any
settlement of any pending or threatened action in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party unless such settlement includes an
unconditional release of such indemnified party from all liability on any claims
that are the subject matter of such action. Anything in this Section
9 to the contrary notwithstanding an indemnifying party shall not be liable for
any settlement of a claim effected without its written consent, which consent
shall not be unreasonably withheld.
26
(d) If the
indemnification provided for in this Section 9 is unavailable or insufficient to
hold harmless an indemnified party under Section 9(a) or (b) hereof in respect
of any losses, liabilities, claims, damages or expenses (or actions, inquiries,
investigations or proceedings in respect thereof) referred to therein, except by
reason of the failure to give notice as required in Section 9(c) hereof
(provided that the indemnifying party does not have knowledge of the action,
inquiry, investigation or proceeding and to the extent such party has been
materially prejudiced by the failure to give such notice), then each
indemnifying party shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, liabilities, claims, damages or
expenses (or actions, inquiries, investigations or proceedings in respect
thereof in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other from
the offering of the Shares. If, however, the allocation provided by
the immediately preceding sentence is not permitted by applicable law, then each
indemnifying party shall contribute to such amount paid or payable by such
indemnified party in such proportion as is appropriate to reflect not only such
relative benefits but also the relative fault of the Company on the one hand and
the Underwriters on the other in connection with the statements or omissions
which resulted in such losses, liabilities, claims or expenses (or actions,
inquiries, investigations or proceedings in respect thereof), as well as any
other relevant equitable considerations. The relative benefits
received by the Company on the one hand and the Underwriters on the other shall
be deemed to be in the same proportion as the total net proceeds from the
offering (before deducting expenses) received by the Company bears to the total
underwriting discount and commissions received by the Underwriters, in each case
as set forth in the table on the cover page of the Prospectus. The
relative fault shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the
Company on the one hand or the Underwriters on the other hand and the parties’
relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.
The
Company and the Underwriters agree that it would not be just and equitable if
contributions to this Section 9(d) were determined by pro rata allocation (even
if the Underwriters were treated as one entity for such purpose) or by any other
method of allocation that does not take account of the equitable considerations
referred to above in this Section 9(d). The amount paid or payable by
an indemnified party as a result of the losses, liabilities, claims, damages or
expenses (or actions, inquiries, investigations or proceedings in respect
thereof) referred to above in this Section 9(d) shall be deemed to include any
legal or other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or
claim. Notwithstanding the provisions of this Section 9(d), (i) the
provisions of the Agreement Among Underwriters shall govern contribution among
Underwriters, (ii) no Underwriter (except as provided in the Agreement Among
Underwriters) shall be required to contribute any amount in excess of the
underwriting discounts and commissions applicable to the Shares purchased by
such Underwriter, and (iii) no person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters’ obligations in this Section 9(d)
to contribute are several in proportion to their individual underwriting
obligations and not joint.
27
10. Representations and
Agreements to Survive Delivery. Except
as the context otherwise requires, all representations, warranties and
agreements contained in this Agreement shall be deemed to be representations,
warranties and agreements at the Closing Date and any Option Closing
Date. All such representations, warranties and agreements of the
Underwriters and the Company, including, without limitation, the indemnity and
contribution agreements contained in Section 9 hereof and the agreements
contained in Sections 5, 7, 11 and 12 hereof, shall remain operative and in full
force and effect regardless of any investigation made by or on behalf of the
Underwriters or any controlling person, and shall survive delivery of the Shares
and termination of this Agreement, whether before or after the Closing Date or
any Option Closing Date.
11. Effective
Time of This Agreement and Termination Hereof.
(a) This
Agreement shall become effective at 10:00 a.m., Philadelphia, Pennsylvania
time, on the first business day following the Effective Time or at the time of
the public offering by the Underwriters of the Shares, whichever is later,
except that the provisions of Sections 7, 9, 10 and 11 hereof shall be effective
upon execution hereof. The time of the public offering, for the
purpose of this Section 11, shall mean the time when any of the Shares are first
released by the Underwriters for offering by dealers. The
Representatives and the Company may prevent the provisions of this Agreement
(other than those contained in Sections 7, 9, 10 and 11) hereof from becoming
effective without liability of any party to any other party, except as noted
below, by giving the notice indicated in Section 11(c) hereof before the time
the other provisions of this Agreement become effective.
(b) The
Representatives shall have the right to terminate this Agreement at any time
prior to the Closing Date or any Option Closing Date as provided in Sections 8
and 12 or if any of the following have occurred: (i) since the
respective dates as of which information is given in the Registration Statement
and the Prospectus, any material adverse change or any development involving a
prospective material adverse change in or affecting the Business Conditions of
the Company or any of the Subsidiaries, whether or not arising in the ordinary
course of business, that would, in the Representatives’ opinion, make the
offering or delivery of the Shares impracticable; (ii) any outbreak or
escalation of hostilities or other national or international calamity or crisis
or change in economic, political or financial market conditions if the effect on
the financial markets of the United States of such outbreak, calamity, crisis or
change would, in the Representatives’ opinion, make the offering or delivery of
the Shares impracticable; (iii) any suspension or limitation of trading
generally in securities on Nasdaq or the over the counter market or any setting
of minimum prices for trading (other than ordinary course limitations on hours
or numbers of days trading) for securities on such exchange or market or the
promulgation of any federal or state statute, regulation, rule or order of any
court or other governmental authority that in the Representatives’ opinion
materially and adversely affects trading on such exchange or over the counter
market; (iv) the enactment, publication, decree or other promulgation of any
federal or state statute, regulation, rule or order of any court or other
governmental authority which in the Representatives’ opinion materially and
adversely affects or will materially or adversely affect the Business Conditions
of the Company; (v) declaration of a banking moratorium by the United States,
New York, New Jersey or Pennsylvania
authorities; (vi) the taking of any action by any federal, state or local
government or agency in respect of its monetary or fiscal affairs that in the
Representatives’ opinion has a material adverse effect on the securities markets
in the United States; or (vii) trading in any securities of the Company shall
have been suspended or halted by Nasdaq or the SEC.
28
(c) If the
Representatives elect to prevent this Agreement from becoming effective or to
terminate this Agreement as provided in this Section 11, the Representatives
shall notify the Company hereof promptly by telephone, telex, telegraph,
telegram or facsimile, confirmed by letter.
12. Default
by an Underwriter.
(a) If any
Underwriter or Underwriters shall default in its or their obligation to purchase
Firm Shares or Optional Shares hereunder, and if the Firm Shares or Optional
Shares with respect to which such default relates do not exceed in the aggregate
10% of the number of Firm Shares or Optional Shares, as the case may be, that
all Underwriters have agreed to purchase on the relevant Closing Date or Option
Closing Date, then the Representatives may make arrangements satisfactory to the
Company for the purchase of such Firm Shares by other persons, including any of
the Underwriters, but if no such arrangements are made by the relevant Closing
Date or Option Closing Date, such Firm Shares or Optional Shares to which the
default relates shall be purchased severally by the non-defaulting Underwriters
in proportion to their respective commitments hereunder.
(b) If such
default relates to more than 10% of the Firm Shares or Optional Shares, as the
case may be, the Representatives may in their discretion arrange for another
party or parties (including a non-defaulting Underwriter) to purchase such Firm
Shares or Optional Shares to which such default relates, on the terms contained
herein. In the event that the Representatives do not arrange for the
purchase of the Firm Shares or Optional Shares to which a default relates as
provided in this Section 12, this Agreement may be terminated by the
Representatives or by the Company without liability on the part of the
non-defaulting several Underwriters (except as provided in Section 9 hereof) or
the Company (except as provided in Sections 7 and 9 hereof); provided that if
such default occurs with respect to Optional Shares after the Closing Date, this
Agreement will not terminate as to the Firm Shares or any Optional Shares
purchased prior to such termination. Nothing herein shall relieve a
defaulting Underwriter of its liability, if any, to the other several
Underwriters and to the Company for damages occasioned by its default
hereunder.
(c) If the
Firm Shares or Optional Shares to which the default relates are to be purchased
by the non-defaulting Underwriters, or are to be purchased by another party or
parties, the Representatives or the Company shall have the right to postpone the
Closing Date or any Option Closing Date, as the case may be, for a reasonable
period but not in any event exceeding seven days, in order to effect whatever
changes may thereby be made necessary in the Registration Statement or the
Prospectus or in any other documents and arrangements, and the Company agrees to
file promptly any amendment to the Registration Statement or supplement to the
Prospectus that in the opinion of counsel for the Underwriters may thereby be
made necessary. The terms “Underwriters” and “Underwriter” as used in
this Agreement shall include any party substituted under this Section 12 with
like effect as if it had originally been a party to this Agreement with respect
to such Firm Shares and/or Optional Shares.
29
13. Information Furnished by the
Underwriters. The
identity of the Underwriters set forth in the first paragraph under the heading
“Underwriting,” the concession and reallowance figures appearing in the third
paragraph under the heading “Underwriting,” the representations with respect to
stabilization activities in the seventh paragraph under the heading
“Underwriting,” the eighth through eleventh paragraphs under the heading
“Underwriting” regarding syndicate covering transactions, naked short selling,
penalty bids and passive market making and discretionary authority in the
thirteenth paragraph under the heading “Underwriting” constitute the only
written information furnished by reference or on behalf of any of the
Underwriters referred to in Sections 1(c), 1(d) and 1(e) and 9
hereof.
14. Notice. All
communications hereunder, except as herein otherwise specifically provided,
shall be in writing and, if sent to any Underwriter, shall be mailed, delivered,
telexed, telegrammed, telegraphed or telecopied and confirmed to Xxxxxx
Xxxxxxxxxx Xxxxx LLC, 0000 Xxxxxx Xxxxxx, Xxxxxxxxxxxx, Xxxxxxxxxxxx 00000,
Attention: Xxxxxx X. Xxxxxx, Xx., facsimile number (000) 000-0000,
with a copy to Xxxxxxx Xxxxx LLP, 0000 Xxxxxx Xxxxxx, Xxxxxxxxxxxx, Xxxxxxxxxxxx
00000, Attention: Xxxxxx X. Xxxxx, Esquire, facsimile number (000)
000-0000; and if sent to the Company, shall be mailed, delivered, telexed,
telegrammed, telegraphed or telecopied and confirmed to Middlesex Water Company,
0000 Xxxxxx Xxxx, Xxxxxx, Xxx Xxxxxx, 00000, Attention: A. Xxxxx
X’Xxxxxx, facsimile number (000) 000-0000, with a copy to Xxxxxx, XxXxxxxxxx
& Xxxxxx, P.A., 000 Xxxxx 000-000, Xxxxxxxxxxx, Xxx Xxxxxx 00000, Attention:
Xxxxxxx X. Xxxxx, Esquire, facsimile number (000) 000-0000.
15. Parties. This
Agreement shall inure solely to the benefit of, and shall be binding upon, the
several Underwriters, the Company and the controlling persons, directors and
officers of each, and their respective successors, assigns, heirs and legal
representatives, and no other person shall have or be construed to have any
legal or equitable right, remedy or claim under or in respect of or by virtue of
this Agreement or any provision herein contained. The terms
“successors” and “assigns” shall not include any purchaser of the Shares merely
because of such purchase.
16. Definition of Business
Day. For
purposes of this Agreement, “business day” means any day on which Nasdaq is
opened for trading.
17. Counterparts. This
Agreement may be executed in one or more counterparts (including by means of any
standard form of communication) and all such counterparts will constitute one
and the same instrument.
18. Construction. This
Agreement shall be governed by and construed in accordance with the laws of the
Commonwealth of Pennsylvania applicable to agreements made and performed
entirely within such Commonwealth.
30
19. Amendments or
Waivers. No
amendment or waiver of any provision of this Agreement, and no consent or
approval to any departure therefrom, shall in any event be effective unless the
same shall be in writing and signed by the parties thereto.
20. Partial
Unenforceability. The
invalidity or unenforceability of any Section, paragraph or provision of this
Agreement shall not affect the validity or enforceability of any other Section,
paragraph or provision hereof. If any Section, paragraph or provision
of this Agreement is for any reason determined to be invalid or unenforceable,
there shall be deemed to be made such minor changes (and only such minor
changes) as are necessary to make it valid and enforceable.
21. Consent to
Jurisdiction. Any
legal suit, action or proceeding arising out of or based upon this Agreement or
the transactions contemplated hereby (“Related Proceedings”) must be instituted
in the federal courts of the United States of America or the courts of the
Commonwealth of Pennsylvania in each case located in the City and County of
Philadelphia (collectively, the “Specified Courts”), and each party irrevocably
submits to the exclusive jurisdiction (except for proceedings instituted in
regard to the enforcement of a judgment of any such court (a “Related
Judgment”), as to which such jurisdiction is non-exclusive) of such courts in
any such suit, action or proceeding. Service of any process, summons,
notice or document by certified mail to such party’s address set forth above
shall be effective service of process for any suit, action or other proceeding
brought in any such court. The parties irrevocably and
unconditionally waive any objection that the laying of venue of any suit, action
or other proceeding brought in any such court has been brought in an
inconvenient forum.
22. Entire
Agreement. This
Agreement constitutes the entire agreement of the parties to this Agreement and
supersedes all prior written or oral and all contemporaneous oral agreements,
understandings and negotiations with respect to the subject matter
hereof.
23. Sophisticated Parties; No
Fiduciary Relationship. Each
of the parties hereto acknowledges that it is a sophisticated business person
who was adequately represented by counsel during negotiations regarding the
provisions hereof, including, without limitation, the indemnification and
contribution provisions of Section 9, and is fully informed regarding said
provisions. Each of the parties hereto further acknowledges that the
provisions of Section 9 hereto fairly allocate the risks in light of the ability
of the parties to investigate the Company, its affairs and its business in order
to assure that adequate disclosure has been made in the Registration Statement,
the Disclosure Package and the Prospectus (and any amendments and supplements
thereto), as required by the Act and the Exchange Act. The Company
acknowledges and agrees that in connection with all aspects of each transaction
contemplated by this Agreement, the Company, on the one hand, and the
Underwriters, on the other hand, have an arms-length business relationship that
creates no fiduciary duty on the part of any Underwriter and each expressly
disclaims any fiduciary relationship.
[Signature
Page Follows]
31
If the
foregoing correctly sets forth your understanding of our agreement, please sign
and return to the Company the enclosed duplicate hereof, whereupon it will
become a binding agreement in accordance with its terms.
Very truly yours, | |||
MIDDLESEX WATER COMPANY | |||
|
By:
|
/s/ A. Xxxxx X’Xxxxxx | |
Name: | A. Xxxxx X’Xxxxxx | ||
Title: | Vice President and Chief Financial Officer | ||
The
foregoing Agreement is hereby confirmed
and
accepted as of the date first above written.
XXXXXX
XXXXXXXXXX XXXXX LLC
XXXXXX
X. XXXXX & CO., L.P.
|
|
By: XXXXXX XXXXXXXXXX XXXXX LLC | ||
By:
|
/s/ Xxxxxx X. Xxxxxx, Xx. | |
Name: | Xxxxxx X. Xxxxxx, Xx. | |
Title: | Managing Director - Head of | |
Infrastructure Group |
On behalf of each of the
Underwriters
named in
Schedule I hereto
[Signature Page to Underwriting
Agreement]
SCHEDULE
I
Schedule
of Underwriters
Underwriter |
Number of Firm
Shares
to
be Purchased
|
Xxxxxx Xxxxxxxxxx Xxxxx LLC |
1,530,000
|
Xxxxxx X. Xxxxx & Co., L.P. |
170,000
|
Total |
1,700,000
|
S-I
SCHEDULE
II
Issuer
Free Writing Prospectus
None.
S-II
SCHEDULE
III
Persons
Who Are To Deliver Lock-Up Agreements
Lock-Up
Agreements are to be delivered by the following persons and entities immediately
prior to the time the SEC declares the Registration Statement
effective:
Middlesex
Water Company
Xxxxxx X.
Xxxx
A. Xxxxx
X’Xxxxxx
J.
Xxxxxxx Xxxxxxxx
Xxxxxxx
Xxxxxx
Xxxx X.
Cutting
Xxxxxx X.
Xxxxx
Xxxx X.
Xxxxxxxxx, M.D.
Xxxx X.
Xxxxxxxx
Xxxxxx X.
Xxxxxxxx
Xxxxxxxx
Xxxxx
Xxxxxxx
X. Xxxxxxx
Xxxxxxx
X. Xxxxx
Xxxxx X.
Xxxxxxx
Xxxxxxxxxx
X. Xxxxxx
Xxxxxx X.
Xxxxxxxx
S-III
EXHIBIT
A
Form of
Lock-Up Agreement
LOCK-UP
AGREEMENT
Middlesex Water Company
0000
Xxxxxx Xxxx
Xxxxxx,
Xxx Xxxxxx 00000
Xxxxxx
Xxxxxxxxxx Xxxxx LLC
Xxxxxx X.
Xxxxx & Co., LP
c/o
Janney Xxxxxxxxxx Xxxxx LLC
0000
Xxxxxx Xxxxxx
Xxxxxxxxxxxx,
XX 00000
Ladies
and Gentlemen:
Reference
is made to a Registration Statement on Form S-3 (File No. 166425) of Middlesex
Water Company (the “Company”) (as the
same may be hereafter amended, the “Registration
Statement”), pursuant to which 5,000,000 shares of the Company’s Common
Stock, no par value (“Common Shares”), have
been registered under the Securities Act of 1933, as amended (the “Act”), for public
sale under a “shelf” offering. A public offering and sale of
1,955,000 of those registered shares will be underwritten by Xxxxxx Xxxxxxxxxx
Xxxxx LLC (“Janney”) and Xxxxxx
Xxxxx & Co., L.P. (collectively, the “Underwriters”). The
undersigned is a director or officer of the Company and holds Common
Shares.
As an
inducement to the Underwriters to underwrite the above-mentioned public sale of
Common Shares, the undersigned hereby agrees, from the date hereof and for a
period of ninety (90) days (the “Lock-Up Period”) from
the date of the Final Prospectus Supplement related to the above-mentioned
public sale of Common Shares (the “Supplement Date”),
not to, directly or indirectly, sell, offer to sell, contract to sell, pledge,
grant any option for the sale or purchase of, agree to sell or otherwise dispose
of (collectively, “Disposition”), any
Common Shares or any securities convertible into or exercisable or exchangeable
for Common Shares beneficially owned by the undersigned now or on the Supplement
Date, or with respect to which the undersigned now or on the Supplement Date has
the power of Disposition, or enter into a transaction which would have the same
effect, or enter into any swap, hedge or other arrangement that transfers, in
whole or in part, any of the economic consequences of ownership of Common
Shares, whether any such aforementioned transaction is to be settled by delivery
of Common Shares or such other securities, in cash or otherwise, or publicly
disclose the intention to make any such Disposition, or to enter into any such
transaction, swap, hedge or other arrangement, without, in each case, the prior
written consent of Janney, on behalf of the Underwriters; provided, however, that if
(i) during the last seventeen (17) days of the Lock-Up Period, (A) the
Company releases earnings results or (B) material news or a material event
relating to the Company occurs, or (ii) prior to the expiration of the
Lock-Up Period, the Company announces that it will release earnings results
during the 16-day period following the last day of the Lock-Up Period; then in
each case the Lock-Up Period will be extended until the expiration of the 18-day
period beginning on the date of the release of the earnings results or the
occurrence of material news or a material event relating to the Company, as the
case may be, unless Janney, on behalf of the Underwriters, waives, in writing,
such extension.
A-1
In
addition, the undersigned agrees that, without the prior written consent of
Janney, on behalf of the Underwriters, it will not, during the Lock-Up Period or
any extension thereof, make any demand for, or exercise any right with respect
to, the registration of any Common Shares or any securities convertible into or
exercisable or exchangeable for Common Shares.
The
foregoing agreement and the representation shall not apply to (i) bona fide
gifts of securities, provided the
recipient of such gift or contribution agrees in writing as a condition
precedent to such gift or contribution to be bound by the terms hereof, or
(ii) transfers of securities to “affiliates” of the transferor if the
transfers do not involve a public distribution or public offering and provided the
transferee agrees in writing as a condition precedent to such transfer to be
bound by the terms hereof. The term “affiliate” shall have the
meaning given such term in Rule 144 under the Act. The transferor
shall notify the Underwriters in writing prior to the transfer, and there shall
be no further transfer of Common Shares or securities convertible into or
exercisable for Common Shares except in accordance with this letter
agreement.
In
furtherance of the foregoing, the Company and its transfer agent are hereby
authorized to decline to make any transfer of securities if such transfer would
constitute a violation or breach of this letter agreement. The
undersigned also agrees and consents to the entry of stock transfer instructions
with the Company’s transfer agent against the transfer of any Common Shares or
securities convertible into or exercisable or exchangeable for Common
Shares.
This
Agreement shall be binding on the undersigned and the successors, heirs,
personal representatives and assigns of the undersigned.
Very truly yours, | |||
|
|
||
Name: | |||
Title: | |||
A-2
EXHIBIT
B
Matters
to be Covered in the Opinion of
Xxxxxx,
XxXxxxxxxx & Xxxxxx, P.A.
Counsel
for the Company
Intentionally
Omitted.
B-1